Categories: Wire Stories

Asahi Kasei Medical Bioprocess Affiliate Opens in China

SHANGHAI–(BUSINESS WIRE)–Asahi Kasei Medical announces that an affiliated company in China, Asahi Kasei Bioprocess (Shanghai) Co., Ltd. (AKBC), started business on April 1, 2021.


Asahi Kasei Medical is the global market leader in virus filtration, with its Planova� filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. We aim to provide “Assurance Beyond Expectation” to ensure product safety and manufacturing efficiency for therapeutics within the biopharmaceutical industry in the form of innovative yet exceptionally reliable purification consumables, equipment and support services.

The global COVID-19 pandemic has increased demand for Planova™ filters as pharmaceutical companies rapidly develop and mass-produce anti-coronavirus agents. Asahi Kasei Medical continues to reinforce its global supply infrastructure for Planova™ in order to support the early provision of coronavirus vaccines and therapies to as many people as possible.

The launch of AKBC facilitates business expansion in China by localizing inventory management and order processing for shorter delivery times while enabling settlement denominated in Chinese yuan. AKBC will also provide deep technical advice and support as well as hands-on training to enable local customers to use the products with greater ease.

Asahi Kasei Medical contributes to life and living for people around the world as a member of the Asahi Kasei Group’s Health Care Sector, enabling biologics manufacturers to safely and efficiently produce medicines that patients can trust.

Corporate Profile of Asahi Kasei Bioprocess (Shanghai) Co., Ltd.

Location:

999 Huaihai Road, Huai Hai Lu Xi Duan, Xuhui District, Shanghai, China

President:

Weichao Zhu

Business content:

  • Import and sale of Planova™ virus removal filters and bioprocess related products and provision of related technical support
  • Provision of technical support related to bioprocess equipment

Establishment:

August 2020 (operation started in April 2021)

Shareholder:

Asahi Kasei (China) Co., Ltd. 100%

 

Contacts

For more information, please contact:

Ryo Kobayashi

Corporate Communications

Asahi Kasei Corp.

Phone: +81-(0)3-6699-3008

Alex

Recent Posts

LEO Pharma Announces Topline Results of Phase 3 Trial in China for Enstilar® (LEO 90100) Demonstrating Superiority in Adult Chinese Subjects With Stable Plaque Psoriasis

Enstilar® (LEO 90100) showed superiority over Daivobet® ointment in primary and both secondary endpoints in…

2 hours ago

Apromore Named a Leader in the 2024 Gartner® Magic Quadrant™ for Process Mining Platforms Report

Recognized a Leader for Second Consecutive Year Based on Completeness Of Vision and Ability To…

3 hours ago

Luxshare Precision Reinforces Commitment to Ethical Practices

HONG KONG SAR - Media OutReach Newswire - 7 May 2024 - Luxshare Precision, a…

3 hours ago

ServiceNow and Fujitsu announce strategic commitment to launch innovative cross-industry solutions

ServiceNow’s AI platform for digital business, combined with Fujitsu industry expertise, will maximize value for…

4 hours ago

Cessna SkyCourier Receives Type Certification in Australia, Revolutionizing Regional Connectivity

WICHITA, Kan.--(BUSINESS WIRE)--Textron Aviation today announced the Cessna SkyCourier twin utility turboprop has been awarded…

5 hours ago

VinFast starts accepting deposits for mini-SUV VF 3 in Vietnam

HANOI, VIETNAM - Media OutReach Newswire - 7 May 2024 - VinFast Auto (Nasdaq: VFS)…

5 hours ago